Casdin Partners Master Fund, L.P.

Insider Reports History

Entity
Company
Location
Walker House, 87 Mary Street, George Town, Cayman Islands
Signature
Casdin Partners Master Fund, LP, By: Casdin Partners GP, LLC, its General Partner, By: /s/ Eli Casdin, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Casdin Partners Master Fund, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOLIFE SOLUTIONS INC 10%+ Owner Common Stock, par value $.001 per share 8.71M $153M $17.54 Apr 30, 2024 Direct
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 54M $118M $2.19 Aug 27, 2024 Indirect
MAXCYTE, INC. 10%+ Owner Common Stock, par value $0.01 per share 10M $45.3M $4.53 Oct 3, 2022 Direct
Verve Therapeutics, Inc. 10%+ Owner Common Stock 2.42M $24.2M $10.00 Jun 21, 2021 Direct
Absci Corp Director Common Stock 6.75M $7.42M $1.10 Jul 26, 2021 Direct
STANDARD BIOTOOLS INC. Director, 10%+ Owner Common Stock 2.78M $6.08M $2.19 Aug 27, 2024 Direct
Tenaya Therapeutics, Inc. 10%+ Owner Common Stock 362K $1.54M $4.26 Aug 3, 2021 Indirect
Absci Corp Director Common Stock 973K $1.07M $1.10 Jul 26, 2021 Indirect
BIOLIFE SOLUTIONS INC 10%+ Owner Common Stock, par value $.001 per share 0 $0 $17.54 Apr 30, 2024 Indirect
STANDARD BIOTOOLS INC. Director, 10%+ Owner Series B-1 Convertible Preferred Stock 0 $0 $2.75 Mar 18, 2024 Indirect
Absci Corp Director Convertible Note 0 Jul 26, 2021 Direct
Absci Corp Director Convertible Note 0 Jul 26, 2021 Indirect
Absci Corp Director Series E Preferred Stock 0 Jul 26, 2021 Direct
Tenaya Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Aug 3, 2021 Indirect
Tenaya Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 Aug 3, 2021 Indirect
Verve Therapeutics, Inc. 10%+ Owner Series A-2 Preferred Stock 0 Jun 21, 2021 Direct
Verve Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Jun 21, 2021 Direct

Insider Reports Filed by Casdin Partners Master Fund, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LAB STANDARD BIOTOOLS INC. Aug 27, 2024 1 $547K 4 Aug 29, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Aug 22, 2024 3 $1.55M 4 Aug 26, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Aug 19, 2024 3 $2.35M 4 Aug 21, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Aug 14, 2024 1 $1.91M 4 Aug 16, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Aug 9, 2024 3 $2.56M 4 Aug 13, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Aug 7, 2024 2 $1.72M 4 Aug 9, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Aug 2, 2024 2 $1.95M 4 Aug 6, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Jun 18, 2024 3 $0 4 Jun 21, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. May 23, 2024 1 $260K 4 May 28, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. May 20, 2024 3 $1.54M 4 May 22, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. May 15, 2024 3 $3.46M 4 May 17, 2024 Director, 10%+ Owner
BLFS BIOLIFE SOLUTIONS INC Apr 30, 2024 2 $0 4 May 2, 2024 10%+ Owner
LAB STANDARD BIOTOOLS INC. Mar 18, 2024 4 $127M 4 Mar 20, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Mar 4, 2024 2 $646K 4 Mar 6, 2024 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Jan 5, 2024 2 $0 4 Jan 9, 2024 Director, 10%+ Owner
BLFS BIOLIFE SOLUTIONS INC Oct 19, 2023 1 $10.4M 4 Oct 23, 2023 10%+ Owner
BLFS BIOLIFE SOLUTIONS INC Aug 9, 2023 1 $772K 4 Aug 11, 2023 10%+ Owner
BLFS BIOLIFE SOLUTIONS INC May 19, 2023 2 $1.67M 4 May 23, 2023 10%+ Owner
LAB STANDARD BIOTOOLS INC. May 17, 2023 3 $2.63M 4 May 19, 2023 Director, 10%+ Owner
BLFS BIOLIFE SOLUTIONS INC May 16, 2023 3 $1.59M 4 May 18, 2023 10%+ Owner
MXCT MAXCYTE, INC. Oct 3, 2022 1 -$4.53M 4 Oct 5, 2022 10%+ Owner
MXCT MAXCYTE, INC. Jul 1, 2022 1 -$13.9M 4 Jul 6, 2022 10%+ Owner
LAB STANDARD BIOTOOLS INC. Apr 4, 2022 1 $0 4 Apr 6, 2022 Director, 10%+ Owner
LAB STANDARD BIOTOOLS INC. Apr 4, 2022 0 $0 3 Apr 6, 2022 Director
BLFS BIOLIFE SOLUTIONS INC Sep 1, 2021 1 $0 4/A May 19, 2023 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Aug 3, 2021 6 $12.8M 4 Aug 4, 2021 10%+ Owner
MXCT MAXCYTE, INC. Jul 30, 2021 1 $23.4M 4 Aug 3, 2021 10%+ Owner
MXCT MAXCYTE, INC. Jul 29, 2021 0 $0 3 Jul 30, 2021 10%+ Owner
TNYA Tenaya Therapeutics, Inc. Jul 29, 2021 0 $0 3 Jul 29, 2021 10%+ Owner
ABSI Absci Corp Jul 26, 2021 7 -$538K 4 Jul 28, 2021 Director
ABSI Absci Corp Jul 21, 2021 0 $0 3 Jul 21, 2021 Director, 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 21, 2021 5 $20.9M 4 Jun 22, 2021 10%+ Owner
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner